{"id":"https://openalex.org/W3212445909","doi":"https://doi.org/10.1182/blood-2021-148536","title":"Discovery of Prolyl-tRNA Synthetase As a Novel Target in Multiple Myeloma","display_name":"Discovery of Prolyl-tRNA Synthetase As a Novel Target in Multiple Myeloma","publication_year":2021,"publication_date":"2021-11-05","ids":{"openalex":"https://openalex.org/W3212445909","doi":"https://doi.org/10.1182/blood-2021-148536","mag":"3212445909"},"language":"en","primary_location":{"id":"doi:10.1182/blood-2021-148536","doi":"https://doi.org/10.1182/blood-2021-148536","is_oa":false,"landing_page_url":"https://doi.org/10.1182/blood-2021-148536","pdf_url":null,"source":{"id":"https://openalex.org/S200071133","display_name":"Blood","issn_l":"0006-4971","issn":["0006-4971","1528-0020"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Blood","raw_type":"journal-article"},"volume":null,"type":"conference-abstract","indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5059549843","display_name":"Keiji Kurata","orcid":"https://orcid.org/0000-0003-1060-9218","observed_orcids":["https://orcid.org/0000-0003-1060-9218"]},"institutions":[{"id":"https://openalex.org/I136199984","display_name":"Harvard University","ror":"https://ror.org/03vek6s52","country_code":"US","type":"education","lineage":["https://openalex.org/I136199984"]},{"id":"https://openalex.org/I4210117453","display_name":"Dana-Farber Cancer Institute","ror":"https://ror.org/02jzgtq86","country_code":"US","type":"facility","lineage":["https://openalex.org/I4210117453"]},{"id":"https://openalex.org/I4210134579","display_name":"Dana-Farber/Harvard Cancer Center","ror":"https://ror.org/03pvyf116","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I136199984","https://openalex.org/I4210117453","https://openalex.org/I4210134579"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Keiji Kurata","raw_affiliation_strings":["Jerome Lipper Multiple Myeloma Center, LeBow Institute for Myeloma Therapeutics, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Jerome Lipper Multiple Myeloma Center, LeBow Institute for Myeloma Therapeutics, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA","institution_ids":["https://openalex.org/I136199984","https://openalex.org/I4210117453","https://openalex.org/I4210134579"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5104010632","display_name":"Anna-James Bott","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I40120149","display_name":"University of Oxford","ror":"https://ror.org/052gg0110","country_code":"GB","type":"education","lineage":["https://openalex.org/I40120149"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Anna-James Bott","raw_affiliation_strings":["Botnar Research Centre, Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences, University of Oxford, Oxford, United Kingdom"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Botnar Research Centre, Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences, University of Oxford, Oxford, United Kingdom","institution_ids":["https://openalex.org/I40120149"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5091207345","display_name":"Teru Hideshima","orcid":"https://orcid.org/0000-0003-2939-6224","observed_orcids":["https://orcid.org/0000-0003-2939-6224"]},"institutions":[{"id":"https://openalex.org/I136199984","display_name":"Harvard University","ror":"https://ror.org/03vek6s52","country_code":"US","type":"education","lineage":["https://openalex.org/I136199984"]},{"id":"https://openalex.org/I4210117453","display_name":"Dana-Farber Cancer Institute","ror":"https://ror.org/02jzgtq86","country_code":"US","type":"facility","lineage":["https://openalex.org/I4210117453"]},{"id":"https://openalex.org/I4210134579","display_name":"Dana-Farber/Harvard Cancer Center","ror":"https://ror.org/03pvyf116","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I136199984","https://openalex.org/I4210117453","https://openalex.org/I4210134579"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Teru Hideshima","raw_affiliation_strings":["The LeBow Institute for Myeloma Therapeutics and Jerome Lipper Multiple Myeloma Center, Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"The LeBow Institute for Myeloma Therapeutics and Jerome Lipper Multiple Myeloma Center, Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA","institution_ids":["https://openalex.org/I136199984","https://openalex.org/I4210117453","https://openalex.org/I4210134579"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5012817393","display_name":"James E. Dunford","orcid":"https://orcid.org/0000-0002-9932-4042","observed_orcids":["https://orcid.org/0000-0002-9932-4042"]},"institutions":[{"id":"https://openalex.org/I40120149","display_name":"University of Oxford","ror":"https://ror.org/052gg0110","country_code":"GB","type":"education","lineage":["https://openalex.org/I40120149"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"James Dunford","raw_affiliation_strings":["Botnar Research Centre, Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences, University of Oxford, Oxford, United Kingdom"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Botnar Research Centre, Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences, University of Oxford, Oxford, United Kingdom","institution_ids":["https://openalex.org/I40120149"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5038455965","display_name":"Filiz Senbabaoglu","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I40120149","display_name":"University of Oxford","ror":"https://ror.org/052gg0110","country_code":"GB","type":"education","lineage":["https://openalex.org/I40120149"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Filiz Senbabaoglu","raw_affiliation_strings":["Botnar Research Centre, Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences, University of Oxford, Oxford, United Kingdom"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Botnar Research Centre, Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences, University of Oxford, Oxford, United Kingdom","institution_ids":["https://openalex.org/I40120149"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5055194790","display_name":"C. Johansson","orcid":"https://orcid.org/0000-0002-7431-3208","observed_orcids":["https://orcid.org/0000-0002-7431-3208"]},"institutions":[{"id":"https://openalex.org/I40120149","display_name":"University of Oxford","ror":"https://ror.org/052gg0110","country_code":"GB","type":"education","lineage":["https://openalex.org/I40120149"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Catrine Johansson","raw_affiliation_strings":["Botnar Research Centre, Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences, University of Oxford, Oxford, United Kingdom"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Botnar Research Centre, Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences, University of Oxford, Oxford, United Kingdom","institution_ids":["https://openalex.org/I40120149"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5045781099","display_name":"Adam P. Cribbs","orcid":"https://orcid.org/0000-0001-5288-3077","observed_orcids":["https://orcid.org/0000-0001-5288-3077"]},"institutions":[{"id":"https://openalex.org/I40120149","display_name":"University of Oxford","ror":"https://ror.org/052gg0110","country_code":"GB","type":"education","lineage":["https://openalex.org/I40120149"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Adam Cribbs","raw_affiliation_strings":["Botnar Research Centre, Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences, University of Oxford, Oxford, United Kingdom","Oxford Centre for Translational Myeloma Research, Botnar Research Centre, University of Oxford, Oxford, United Kingdom"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Botnar Research Centre, Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences, University of Oxford, Oxford, United Kingdom","institution_ids":["https://openalex.org/I40120149"]},{"raw_affiliation_string":"Oxford Centre for Translational Myeloma Research, Botnar Research Centre, University of Oxford, Oxford, United Kingdom","institution_ids":["https://openalex.org/I40120149"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5070641211","display_name":"Martin Philpott","orcid":"https://orcid.org/0000-0003-3632-0084","observed_orcids":["https://orcid.org/0000-0003-3632-0084"]},"institutions":[{"id":"https://openalex.org/I40120149","display_name":"University of Oxford","ror":"https://ror.org/052gg0110","country_code":"GB","type":"education","lineage":["https://openalex.org/I40120149"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Martin Philpott","raw_affiliation_strings":["Botnar Research Centre, Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences, University of Oxford, Oxford, United Kingdom"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Botnar Research Centre, Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences, University of Oxford, Oxford, United Kingdom","institution_ids":["https://openalex.org/I40120149"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5014737228","display_name":"Sarah Gooding","orcid":"https://orcid.org/0000-0002-1549-7043","observed_orcids":["https://orcid.org/0000-0002-1549-7043"]},"institutions":[{"id":"https://openalex.org/I40120149","display_name":"University of Oxford","ror":"https://ror.org/052gg0110","country_code":"GB","type":"education","lineage":["https://openalex.org/I40120149"]},{"id":"https://openalex.org/I4210110594","display_name":"MRC Weatherall Institute of Molecular Medicine","ror":"https://ror.org/01q496a73","country_code":"GB","type":"facility","lineage":["https://openalex.org/I40120149","https://openalex.org/I4210087105","https://openalex.org/I4210110594","https://openalex.org/I90344618"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Sarah Gooding","raw_affiliation_strings":["Oxford Centre for Translational Myeloma Research, University of Oxford, Oxford, United Kingdom","Weatherall Institute of Molecular Medicine, University of Oxford, Oxford, United Kingdom"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Oxford Centre for Translational Myeloma Research, University of Oxford, Oxford, United Kingdom","institution_ids":["https://openalex.org/I40120149"]},{"raw_affiliation_string":"Weatherall Institute of Molecular Medicine, University of Oxford, Oxford, United Kingdom","institution_ids":["https://openalex.org/I40120149","https://openalex.org/I4210110594"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5111962724","display_name":"Leona Yamamoto","orcid":"https://orcid.org/0000-0001-7120-1211","observed_orcids":["https://orcid.org/0000-0001-7120-1211"]},"institutions":[{"id":"https://openalex.org/I136199984","display_name":"Harvard University","ror":"https://ror.org/03vek6s52","country_code":"US","type":"education","lineage":["https://openalex.org/I136199984"]},{"id":"https://openalex.org/I4210117453","display_name":"Dana-Farber Cancer Institute","ror":"https://ror.org/02jzgtq86","country_code":"US","type":"facility","lineage":["https://openalex.org/I4210117453"]},{"id":"https://openalex.org/I4210134579","display_name":"Dana-Farber/Harvard Cancer Center","ror":"https://ror.org/03pvyf116","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I136199984","https://openalex.org/I4210117453","https://openalex.org/I4210134579"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Leona Yamamoto","raw_affiliation_strings":["Jerome Lipper Multiple Myeloma Center, LeBow Institute for Myeloma Therapeutics, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Jerome Lipper Multiple Myeloma Center, LeBow Institute for Myeloma Therapeutics, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA","institution_ids":["https://openalex.org/I136199984","https://openalex.org/I4210117453","https://openalex.org/I4210134579"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5041668980","display_name":"Mehmet Samur","orcid":"https://orcid.org/0000-0002-9978-5682","observed_orcids":["https://orcid.org/0000-0002-9978-5682"]},"institutions":[{"id":"https://openalex.org/I136199984","display_name":"Harvard University","ror":"https://ror.org/03vek6s52","country_code":"US","type":"education","lineage":["https://openalex.org/I136199984"]},{"id":"https://openalex.org/I4210117453","display_name":"Dana-Farber Cancer Institute","ror":"https://ror.org/02jzgtq86","country_code":"US","type":"facility","lineage":["https://openalex.org/I4210117453"]},{"id":"https://openalex.org/I4210134579","display_name":"Dana-Farber/Harvard Cancer Center","ror":"https://ror.org/03pvyf116","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I136199984","https://openalex.org/I4210117453","https://openalex.org/I4210134579"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Mehmet K. Samur","raw_affiliation_strings":["Department of Biostatistics and Computational Biology, Dana-Farber Cancer Institute and Harvard School of Public Health, Boston, MA","Jerome Lipper Multiple Myeloma Center, LeBow Institute for Myeloma Therapeutics, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Biostatistics and Computational Biology, Dana-Farber Cancer Institute and Harvard School of Public Health, Boston, MA","institution_ids":["https://openalex.org/I136199984","https://openalex.org/I4210117453","https://openalex.org/I4210134579"]},{"raw_affiliation_string":"Jerome Lipper Multiple Myeloma Center, LeBow Institute for Myeloma Therapeutics, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA","institution_ids":["https://openalex.org/I136199984","https://openalex.org/I4210117453","https://openalex.org/I4210134579"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5019802024","display_name":"Yu\u2010Tzu Tai","orcid":"https://orcid.org/0000-0001-6199-3569","observed_orcids":["https://orcid.org/0000-0001-6199-3569"]},"institutions":[{"id":"https://openalex.org/I136199984","display_name":"Harvard University","ror":"https://ror.org/03vek6s52","country_code":"US","type":"education","lineage":["https://openalex.org/I136199984"]},{"id":"https://openalex.org/I4210117453","display_name":"Dana-Farber Cancer Institute","ror":"https://ror.org/02jzgtq86","country_code":"US","type":"facility","lineage":["https://openalex.org/I4210117453"]},{"id":"https://openalex.org/I4210134579","display_name":"Dana-Farber/Harvard Cancer Center","ror":"https://ror.org/03pvyf116","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I136199984","https://openalex.org/I4210117453","https://openalex.org/I4210134579"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Yu-Tzu Tai","raw_affiliation_strings":["Jerome Lipper Multiple Myeloma Center, LeBow Institute for Myeloma Therapeutics, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Jerome Lipper Multiple Myeloma Center, LeBow Institute for Myeloma Therapeutics, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA","institution_ids":["https://openalex.org/I136199984","https://openalex.org/I4210117453","https://openalex.org/I4210134579"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5078323744","display_name":"Mark A. Tye","orcid":"https://orcid.org/0000-0002-9456-0767","observed_orcids":["https://orcid.org/0000-0002-9456-0767"]},"institutions":[{"id":"https://openalex.org/I136199984","display_name":"Harvard University","ror":"https://ror.org/03vek6s52","country_code":"US","type":"education","lineage":["https://openalex.org/I136199984"]},{"id":"https://openalex.org/I4210087915","display_name":"Massachusetts General Hospital","ror":"https://ror.org/002pd6e78","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210087915","https://openalex.org/I48633490"]},{"id":"https://openalex.org/I4210155419","display_name":"Center for Systems Biology","ror":"https://ror.org/05r3dyn47","country_code":"US","type":"facility","lineage":["https://openalex.org/I136199984","https://openalex.org/I4210087915","https://openalex.org/I4210155419","https://openalex.org/I48633490"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Mark A Tye","raw_affiliation_strings":["Center for Systems Biology, Massachusetts General Hospital, Boston, MA","Harvard Graduate School of Arts and Sciences, Cambridge, MA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Center for Systems Biology, Massachusetts General Hospital, Boston, MA","institution_ids":["https://openalex.org/I4210087915","https://openalex.org/I4210155419"]},{"raw_affiliation_string":"Harvard Graduate School of Arts and Sciences, Cambridge, MA","institution_ids":["https://openalex.org/I136199984"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5038535062","display_name":"N. Connor Payne","orcid":"https://orcid.org/0000-0001-9513-6194","observed_orcids":["https://orcid.org/0000-0001-9513-6194"]},"institutions":[{"id":"https://openalex.org/I136199984","display_name":"Harvard University","ror":"https://ror.org/03vek6s52","country_code":"US","type":"education","lineage":["https://openalex.org/I136199984"]},{"id":"https://openalex.org/I4210087915","display_name":"Massachusetts General Hospital","ror":"https://ror.org/002pd6e78","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210087915","https://openalex.org/I48633490"]},{"id":"https://openalex.org/I4210155419","display_name":"Center for Systems Biology","ror":"https://ror.org/05r3dyn47","country_code":"US","type":"facility","lineage":["https://openalex.org/I136199984","https://openalex.org/I4210087915","https://openalex.org/I4210155419","https://openalex.org/I48633490"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"N Connor Payne","raw_affiliation_strings":["Center for Systems Biology, Massachusetts General Hospital, Boston, MA","Department of Chemistry & Chemical Biology, Harvard University, Cambridge, MA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Center for Systems Biology, Massachusetts General Hospital, Boston, MA","institution_ids":["https://openalex.org/I4210087915","https://openalex.org/I4210155419"]},{"raw_affiliation_string":"Department of Chemistry & Chemical Biology, Harvard University, Cambridge, MA","institution_ids":["https://openalex.org/I136199984"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5018125274","display_name":"Patrick Ryan Hagner","orcid":"https://orcid.org/0000-0002-8577-0105","observed_orcids":["https://orcid.org/0000-0002-8577-0105"]},"institutions":[{"id":"https://openalex.org/I4210091812","display_name":"Bristol-Myers Squibb (United States)","ror":"https://ror.org/00gtmwv55","country_code":"US","type":"company","lineage":["https://openalex.org/I4210091812"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Patrick Hagner","raw_affiliation_strings":["Bristol Myers Squib, Summit, NJ"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Bristol Myers Squib, Summit, NJ","institution_ids":["https://openalex.org/I4210091812"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5072918409","display_name":"Karthik Ramasamy","orcid":"https://orcid.org/0000-0003-3385-3707","observed_orcids":["https://orcid.org/0000-0003-3385-3707"]},"institutions":[{"id":"https://openalex.org/I40120149","display_name":"University of Oxford","ror":"https://ror.org/052gg0110","country_code":"GB","type":"education","lineage":["https://openalex.org/I40120149"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Karthik Ramasamy","raw_affiliation_strings":["Oxford Centre for Translational Myeloma Research, Botnar Research Centre, University of Oxford, Oxford, United Kingdom","Radcliffe Department of Medicine, University of Oxford, Oxford, United Kingdom"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Oxford Centre for Translational Myeloma Research, Botnar Research Centre, University of Oxford, Oxford, United Kingdom","institution_ids":["https://openalex.org/I40120149"]},{"raw_affiliation_string":"Radcliffe Department of Medicine, University of Oxford, Oxford, United Kingdom","institution_ids":["https://openalex.org/I40120149"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5028526208","display_name":"Anjan Thakurta","orcid":"https://orcid.org/0000-0003-0415-1706","observed_orcids":["https://orcid.org/0000-0003-0415-1706"]},"institutions":[{"id":"https://openalex.org/I40120149","display_name":"University of Oxford","ror":"https://ror.org/052gg0110","country_code":"GB","type":"education","lineage":["https://openalex.org/I40120149"]},{"id":"https://openalex.org/I4210091812","display_name":"Bristol-Myers Squibb (United States)","ror":"https://ror.org/00gtmwv55","country_code":"US","type":"company","lineage":["https://openalex.org/I4210091812"]}],"countries":["GB","US"],"is_corresponding":false,"raw_author_name":"Anjan Thakurta","raw_affiliation_strings":["Radcliffe Department of Medicine, University of Oxford, Oxford, United Kingdom","Translational Development and Diagnostics, Bristol Myers Squibb, Summit, NJ"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Radcliffe Department of Medicine, University of Oxford, Oxford, United Kingdom","institution_ids":["https://openalex.org/I40120149"]},{"raw_affiliation_string":"Translational Development and Diagnostics, Bristol Myers Squibb, Summit, NJ","institution_ids":["https://openalex.org/I4210091812"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5067096193","display_name":"Ralph Mazitschek","orcid":"https://orcid.org/0000-0002-1105-689X","observed_orcids":["https://orcid.org/0000-0002-1105-689X"]},"institutions":[{"id":"https://openalex.org/I136199984","display_name":"Harvard University","ror":"https://ror.org/03vek6s52","country_code":"US","type":"education","lineage":["https://openalex.org/I136199984"]},{"id":"https://openalex.org/I4210087915","display_name":"Massachusetts General Hospital","ror":"https://ror.org/002pd6e78","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210087915","https://openalex.org/I48633490"]},{"id":"https://openalex.org/I4210155419","display_name":"Center for Systems Biology","ror":"https://ror.org/05r3dyn47","country_code":"US","type":"facility","lineage":["https://openalex.org/I136199984","https://openalex.org/I4210087915","https://openalex.org/I4210155419","https://openalex.org/I48633490"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Ralph Mazitschek","raw_affiliation_strings":["Center for Systems Biology, Massachusetts General Hospital, Boston, MA","Harvard T.H. Chan School of Public Health, Boston, MA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Center for Systems Biology, Massachusetts General Hospital, Boston, MA","institution_ids":["https://openalex.org/I4210087915","https://openalex.org/I4210155419"]},{"raw_affiliation_string":"Harvard T.H. Chan School of Public Health, Boston, MA","institution_ids":["https://openalex.org/I136199984"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5030288845","display_name":"Udo C. T. Oppermann","orcid":"https://orcid.org/0000-0001-9984-5342","observed_orcids":["https://orcid.org/0000-0001-9984-5342"]},"institutions":[{"id":"https://openalex.org/I40120149","display_name":"University of Oxford","ror":"https://ror.org/052gg0110","country_code":"GB","type":"education","lineage":["https://openalex.org/I40120149"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Udo Oppermann","raw_affiliation_strings":["Botnar Research Centre, Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences, University of Oxford, Oxford, United Kingdom","Oxford Centre for Translational Myeloma Research, Botnar Research Centre, University of Oxford, Oxford, United Kingdom"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Botnar Research Centre, Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences, University of Oxford, Oxford, United Kingdom","institution_ids":["https://openalex.org/I40120149"]},{"raw_affiliation_string":"Oxford Centre for Translational Myeloma Research, Botnar Research Centre, University of Oxford, Oxford, United Kingdom","institution_ids":["https://openalex.org/I40120149"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5032464400","display_name":"Kenneth Carl Anderson","orcid":"https://orcid.org/0000-0002-6418-0886","observed_orcids":["https://orcid.org/0000-0002-6418-0886"]},"institutions":[{"id":"https://openalex.org/I4210117453","display_name":"Dana-Farber Cancer Institute","ror":"https://ror.org/02jzgtq86","country_code":"US","type":"facility","lineage":["https://openalex.org/I4210117453"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Kenneth C. Anderson","raw_affiliation_strings":["Jerome Lipper Multiple Myeloma Center, LeBow Institute for Myeloma Therapeutics, Dana-Farber Cancer Institute, Boston, MA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Jerome Lipper Multiple Myeloma Center, LeBow Institute for Myeloma Therapeutics, Dana-Farber Cancer Institute, Boston, MA","institution_ids":["https://openalex.org/I4210117453"]}]}],"institutions":[],"countries_distinct_count":2,"institutions_distinct_count":8,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":{"value":5500,"currency":"USD","value_usd":5500},"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":"138","issue":"Supplement 1","first_page":"890","last_page":"890"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10521","display_name":"RNA and protein synthesis mechanisms","score":0.5009999871253967,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T10521","display_name":"RNA and protein synthesis mechanisms","score":0.5009999871253967,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10649","display_name":"Multiple Myeloma Research and Treatments","score":0.49000000953674316,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11482","display_name":"RNA modifications and cancer","score":0.0031999999191612005,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/multiple-myeloma","display_name":"multiple myeloma","score":0.9049999713897705},{"id":"https://openalex.org/keywords/prolyl-trna-synthetase","display_name":"prolyl-tRNA synthetase","score":0.9549999833106995},{"id":"https://openalex.org/keywords/glutamyl-prolyl-trna-synthetase","display_name":"glutamyl-prolyl-tRNA synthetase","score":0.9020000100135803},{"id":"https://openalex.org/keywords/aminoacyl-trna-synthetase","display_name":"aminoacyl-tRNA synthetase","score":0.953000009059906},{"id":"https://openalex.org/keywords/halofuginone","display_name":"halofuginone","score":0.8080000281333923},{"id":"https://openalex.org/keywords/atp-competitive-inhibitors","display_name":"ATP-competitive inhibitors","score":0.6050000190734863},{"id":"https://openalex.org/keywords/proline","display_name":"proline","score":0.4779999852180481},{"id":"https://openalex.org/keywords/gcn2","display_name":"GCN2","score":0.7559999823570251},{"id":"https://openalex.org/keywords/eif2alpha-phosphorylation","display_name":"eIF2\u03b1 phosphorylation","score":0.6460000276565552},{"id":"https://openalex.org/keywords/autophagy","display_name":"autophagy","score":0.5260000228881836},{"id":"https://openalex.org/keywords/tumor-microenvironment","display_name":"tumor microenvironment","score":0.47099998593330383},{"id":"https://openalex.org/keywords/drug-resistance","display_name":"drug resistance","score":0.6449999809265137}],"concepts":[{"id":"https://openalex.org/C173396325","wikidata":"https://www.wikidata.org/wiki/Q1501275","display_name":"Gene knockdown","level":3,"score":0.7362035512924194},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.5503309965133667},{"id":"https://openalex.org/C127561419","wikidata":"https://www.wikidata.org/wiki/Q224527","display_name":"Downregulation and upregulation","level":3,"score":0.5096642971038818},{"id":"https://openalex.org/C81885089","wikidata":"https://www.wikidata.org/wiki/Q189082","display_name":"Cell culture","level":2,"score":0.49492114782333374},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.4928703308105469},{"id":"https://openalex.org/C62112901","wikidata":"https://www.wikidata.org/wiki/Q189159","display_name":"Cell growth","level":2,"score":0.47952842712402344},{"id":"https://openalex.org/C2776364478","wikidata":"https://www.wikidata.org/wiki/Q467635","display_name":"Multiple myeloma","level":2,"score":0.44413527846336365},{"id":"https://openalex.org/C555283112","wikidata":"https://www.wikidata.org/wiki/Q1637543","display_name":"Carcinogenesis","level":3,"score":0.44213777780532837},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.367591917514801},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.252479612827301},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.23182305693626404},{"id":"https://openalex.org/C104317684","wikidata":"https://www.wikidata.org/wiki/Q7187","display_name":"Gene","level":2,"score":0.22776895761489868},{"id":"https://openalex.org/C54355233","wikidata":"https://www.wikidata.org/wiki/Q7162","display_name":"Genetics","level":1,"score":0.16716715693473816}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1182/blood-2021-148536","doi":"https://doi.org/10.1182/blood-2021-148536","is_oa":false,"landing_page_url":"https://doi.org/10.1182/blood-2021-148536","pdf_url":null,"source":{"id":"https://openalex.org/S200071133","display_name":"Blood","issn_l":"0006-4971","issn":["0006-4971","1528-0020"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Blood","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"score":0.9789000153541565,"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W4417007035","https://openalex.org/W4315621715","https://openalex.org/W7116980377","https://openalex.org/W2082139628","https://openalex.org/W3214706001","https://openalex.org/W4310105240","https://openalex.org/W2985235279","https://openalex.org/W2526770225","https://openalex.org/W2955408701","https://openalex.org/W2340943962"],"abstract_inverted_index":{"Abstract":[0],"Aminoacyl-tRNA":[1],"synthetases":[2],"(aaRSs)":[3],"are":[4],"essential":[5,541],"enzymes":[6],"that":[7,19,33,83,146,460,555],"charge":[8],"tRNAs":[9,286],"with":[10,105,113,127,251,315,489],"their":[11],"cognate":[12],"amino":[13,290],"acids.":[14],"Recent":[15],"studies":[16,458],"have":[17,60],"revealed":[18,82,437],"the":[20,51,163,186,191,289,300,351,384,527,621],"expression":[21,69,80,96,111],"of":[22,54,71,97,162,167,183,188,275,284,317,338,348,387,417,424,462,491,534,583,626,663,681,699,718,736,750,763,775,788,800,827,838,851,862,873,884,895,902,915,928,940],"aaRSs":[23,48,55,72,85,279],"is":[24,148,159,176,469],"dynamically":[25],"altered":[26,271],"in":[27,39,47,49,56,73,88,132,154,215,282,303,345,350,389,440,485,507,523,543,565,569,572,591,606,609,634,652,814,910,918],"response":[28,292],"to":[29,92,239,375,430,472,511,519,630],"cellular":[30],"stresses,":[31],"and":[32,41,119,138,151,169,180,205,228,312,319,340,367,405,414,427,450,497,515,550,571,586,597,608,614,904],"specific":[34],"isoforms":[35],"play":[36,540],"pivotal":[37],"roles":[38,542],"carcinogenesis":[40],"tumor":[42,74,193,362],"progression.":[43],"Despite":[44],"emerging":[45],"interest":[46],"cancer,":[50],"biologic":[52],"sequelae":[53],"multiple":[57],"myeloma":[58],"(MM)":[59],"not":[61,270],"yet":[62],"been":[63],"elucidated.":[64],"We":[65,342,504,552],"first":[66],"examined":[67,296],"RNA":[68],"levels":[70,182],"cells":[75,134,231,256,487,567],"from":[76,399],"MM":[77,89,133,155,172,216,230,259,304,390,400,544,566,603],"patients.":[78,401],"Gene":[79,432],"analyses":[81],"most":[84],"were":[86,495,499,559],"upregulated":[87,496],"patients":[90],"compared":[91,374,429],"healthy":[93],"donors.":[94],"Importantly,":[95,262],"4":[98],"aaRSs,":[99],"including":[100,190,219,547],"glutamyl-prolyl-tRNA":[101],"synthetase":[102],"(EPRS),":[103],"correlated":[104,112],"worse":[106],"clinical":[107,128,628],"prognosis:":[108],"high":[109,465],"EPRS":[110,147,168,473,579,600],"disease":[114],"progression":[115],"(GSE6477;":[116],"P<":[117],"0.001)":[118,373],"shorter":[120],"survival":[121,152,370],"(CoMMpass;":[122],"P":[123],"=":[124,365],"0.007).":[125],"Consistent":[126],"data,":[129],"ERPS":[130],"knockdown":[131],"(AMO1,":[135],"RPMI":[136],"8226,":[137],"MM.1S)":[139],"triggered":[140,411],"significant":[141,237,438],"cell":[142,217,260,266,327,333,545],"growth":[143,150,214,267,363],"inhibition,":[144],"suggesting":[145],"a":[149,201,481,532,581,587,594,919],"factor":[153],"cells.":[156,243,305],"Halofuginone":[157],"(HF)":[158],"an":[160,273,660,678,696,715,733,747,760,772,785,797,824,835,848,859,870,881,892,925,937],"inhibitor":[161],"prolyl-tRNA-synthetase":[164],"(PRS)":[165],"activity":[166],"potently":[170,212],"inhibits":[171],"growth.":[173],"However,":[174],"HF":[175,404],"proline":[177],"(Pro)":[178],"competitive":[179,204],"increased":[181,309],"Pro":[184,206,598],"abrogates":[185],"effect":[187],"HF,":[189,264],"Pro-rich":[192],"microenvironment.":[194],"To":[195,381],"overcome":[196],"this":[197],"limitation,":[198],"we":[199,294,392,478,530],"developed":[200],"novel":[202,588,595],"ATP":[203],"non-competitive":[207,599],"PRS":[208],"inhibitor,":[209,601],"NCP26.":[210],"NCP26":[211,298,308,323,349,356,388,406,410,454,563],"decreased":[213],"lines,":[218],"drug":[220],"(Dox,":[221],"Dex,":[222],"PI,":[223],"IMiDs)":[224],"resistant":[225],"isogenic":[226],"derivatives,":[227],"patient":[229,632],"(EC50":[232],"\u2248":[233],"500":[234],"nM),":[235],"without":[236,377],"toxicity":[238],"peripheral":[240],"blood":[241],"mononuclear":[242],"Neither":[244],"anti-apoptotic":[245],"cytokines":[246],"(i.e.,":[247],"IL-6)":[248],"nor":[249],"co-culture":[250],"bone":[252],"marrow":[253],"(BM)":[254],"stromal":[255],"abrogated":[257],"NCP26-induced":[258,265],"death.":[261],"unlike":[263],"inhibition":[268,280,474],"was":[269],"by":[272,288,331,336,422,562,611],"excess":[274],"exogenous":[276],"Pro.":[277],"Since":[278,456],"results":[281,577],"accumulation":[283],"uncharged":[285],"sensed":[287],"acid":[291],"(AAR),":[293],"next":[295,479],"whether":[297],"activates":[299],"AAR":[301,613],"pathway":[302],"As":[306],"expected,":[307],"both":[310,403,568,605],"p-GCN2":[311],"p-eIF2\u03b1,":[313],"associated":[314],"upregulation":[316],"ATF4":[318],"CHOP":[320],"expression.":[321],"Moreover,":[322],"treatment":[324,407,564],"induced":[325],"G0/G1":[326],"cycle":[328],"arrest":[329],"followed":[330],"apoptotic":[332],"death,":[334],"evidenced":[335,421],"cleavage":[337],"caspases":[339],"PARP.":[341],"also":[343,436,505,553],"evaluated":[344],"vivo":[346,610],"efficacy":[347],"AMO1":[352,486],"xenograft":[353],"mouse":[354],"model:":[355],"(10":[357],"mg/kg,":[358],"q.d.)":[359],"significantly":[360,560],"inhibited":[361],"(P":[364,371],"0.005)":[366],"prolonged":[368],"host":[369],"<":[372],"control,":[376],"affecting":[378],"body":[379],"weight.":[380],"further":[382],"characterize":[383],"biological":[385],"impact":[386],"cells,":[391],"performed":[393,480,506],"single-cell":[394],"RNA-seq":[395],"using":[396],"BM":[397],"samples":[398],"While":[402],"reduced":[408],"MM,":[409],"more":[412,470],"sustained":[413],"robust":[415],"activation":[416],"integrated":[418],"stress":[419,451],"response,":[420,452],"induction":[423],"GCN2,":[425],"CHOP,":[426],"IRE1,":[428],"HF.":[431],"set":[433],"enrichment":[434],"analysis":[435,484,510],"alteration":[439],"chromatin":[441],"processes,":[442],"besides":[443],"proteostasis,":[444],"such":[445],"as":[446,580],"translation,":[447],"signal":[448],"peptide,":[449],"after":[453,501],"treatment.":[455,503],"previous":[457],"suggested":[459],"translation":[461],"genes":[463],"bearing":[464],"Pro-Pro":[466],"(PP)":[467],"motifs":[468],"susceptible":[471],"than":[475],"non-PP-bearing":[476],"genes,":[477,514],"quantitative":[482],"proteomic":[483],"treated":[488],"NCP26:":[490],"7,366":[492],"proteins,":[493],"84":[494],"363":[498],"downregulated":[500,561],"6-hour":[502],"silico":[508],"bioinformatic":[509],"uncover":[512],"PP-bearing":[513],"incorporated":[516],"CRISPR-screening":[517],"data":[518,619],"identify":[520,578],"genetic":[521],"dependencies":[522],"MM.":[524,592,635],"By":[525],"overlapping":[526],"three":[528],"datasets,":[529],"identified":[531],"group":[533],"55":[535],"PP":[536,556],"motif-containing":[537,557],"proteins":[538,558,616],"which":[539],"pathogenesis,":[546],"MYC,":[548],"PIM2,":[549],"CCND1/2.":[551],"confirmed":[554],"vitro":[570,607],"vivo.":[573],"In":[574],"conclusion,":[575],"our":[576],"biomarker":[582],"poor":[584],"prognosis":[585],"therapeutic":[589],"target":[590],"NCP26,":[593],"ATP-competitive":[596],"induces":[602],"cytotoxicity":[604],"triggering":[612],"EPRS-Pro-rich":[615],"pathways.":[617],"Our":[618],"provide":[620],"preclinical":[622],"rationale":[623],"for":[624],"development":[625],"NCP26-based":[627],"candidates":[629],"improve":[631],"outcomes":[633],"Disclosures":[636],"Gooding:":[637],"Bristol":[638,644,806,843],"Myers":[639,645,807,844],"Squibb:":[640,646,808,845],"Research":[641,672,690,708,727,741],"Funding.":[642],"Hagner:":[643],"Current":[647,649,809,811,907,913],"Employment,":[648,810],"equity":[650,812,908],"holder":[651,813,909,914],"publicly-traded":[653,815,911],"company.":[654],"Ramasamy:":[655],"Amgen:":[656],"Honoraria,":[657,675,693,712,730,744,757,769,782,794],"Membership":[658,676,694,713,731,745,758,770,783,795,822,833,846,857,868,879,890,923,935],"on":[659,677,695,714,732,746,759,771,784,796,823,834,847,858,869,880,891,924,936],"entity's":[661,679,697,716,734,748,761,773,786,798,825,836,849,860,871,882,893,926,938],"Board":[662,680,698,717,735,749,762,774,787,799,826,837,850,861,872,883,894,927,939],"Directors":[664,682,700,719,737,751,764,776,789,801,828,839,852,863,874,885,896,929,941],"or":[665,683,701,720,738,752,765,777,790,802,829,840,853,864,875,886,897,930,942],"advisory":[666,684,702,721,739,753,766,778,791,803,830,841,854,865,876,887,898,931,943],"committees,":[667,685,703,722,740],"Other:":[668,686,704,723],"Travel,":[669,687,705,724],"Conference":[670,688,706,725],"registration,":[671,689,707,726],"Funding;":[673,691,709,728,742],"Janssen:":[674,856],"Takeda:":[692],"Celgene":[710],"(BMS):":[711],"GSK:":[729],"Oncopeptides:":[743],"committees;":[754,767,779,792,831,842,855,866,877,888,899,932],"Adaptive":[755],"biotech:":[756],"Karyopharm:":[768],"Pfizer":[780],"oncology:":[781],"Sanofi:":[793],"committees.":[804,944],"Thakurta:":[805],"company,":[816,912],"Patents":[817],"&":[818],"Royalties.":[819],"Anderson:":[820],"Millenium-Takeda:":[821],"Celgene:":[832],"Gilead:":[867],"Sanofi-Aventis:":[878],"Pfizer:":[889],"Scientific":[900],"Founder":[901],"Oncopep":[903],"C4":[905],"Therapeutics:":[906,934],"individual":[916],"stocks":[917],"privately-held":[920],"company;":[921],"AstraZeneca:":[922],"Mana":[933]},"counts_by_year":[],"updated_date":"2026-10-02T10:15:12.560889","created_date":"2021-11-22T00:00:00"}